These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6376207)

  • 1. The efficacy of a potassium-sparing combination of chlorthalidone and triamterene in the control of mild and moderate hypertension. I.
    Webb EL; Godfrey JC; Gertel A; Costello RJ; Applin WJ; Zisblatt M; Vukovich RA; Neiss ES
    J Int Med Res; 1984; 12(3):133-9. PubMed ID: 6376207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of a potassium-sparing combination of chlorthalidone and triamterene in the control of mild and moderate hypertension. II.
    Webb EL; Godfrey JC; Gertel A; Costello RJ; Cooper WH; Zisblatt M; Vukovich RA; Neiss ES
    J Int Med Res; 1984; 12(3):140-6. PubMed ID: 6376208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorthalidone-triamterene: a potassium-sparing diuretic combination for the treatment of oedema.
    Webb EL; Godfrey JC; Rosenbaum R; Zisblatt M; Vukovich RA; Neiss ES
    J Int Med Res; 1984; 12(3):147-53. PubMed ID: 6376209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in blood pressure, serum potassium and electrolytes with a combination of triamterene and a low dose of chlorthalidone.
    Hort JF; Wilkins HM
    Curr Med Res Opin; 1991; 12(7):430-40. PubMed ID: 1778085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind parallel study of a combination of chlorthalidone 50 mg and triamterene 50 mg in patients with mild and moderate hypertension.
    Spiers DR; Wade RC
    Curr Med Res Opin; 1996; 13(7):409-15. PubMed ID: 8862940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind comparison of hydrochlorothiazide plus triameterene therapy versus chlorthalidone therapy in hypertension.
    Clark EC; Podolsky S; Thompson EJ
    South Med J; 1979 Jul; 72(7):798-802. PubMed ID: 377507
    [No Abstract]   [Full Text] [Related]  

  • 7. Dose response to chlorthalidone in patients with mild hypertension. Efficacy of a lower dose.
    Materson BJ; Oster JR; Michael UF; Bolton SM; Burton ZC; Stambaugh JE; Morledge J
    Clin Pharmacol Ther; 1978 Aug; 24(2):192-8. PubMed ID: 354839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo-controlled trial of a combination of bemetizide and triamterene ('Hypertane') in mild or moderate hypertension.
    Hornung R; Keiso H; Raftery EB; Whittington JR
    Curr Med Res Opin; 1983; 8(6):425-33. PubMed ID: 6342957
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of the antihypertensive efficacy of acebutolol, chlorthalidone and the combination of acebutolol and chlorthalidone in the treatment of mild and moderate primary arterial hypertension].
    Del Nero Júnior E; Lima EV; Savioli RM; de Rezende MC
    Arq Bras Cardiol; 1983 May; 40(5):357-61. PubMed ID: 6360100
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of triamterene on elevated arterial pressure.
    Cranston WI; Semmence AM; Richardson DW; Barnett CF
    Am Heart J; 1965 Oct; 70(4):455-60. PubMed ID: 5319522
    [No Abstract]   [Full Text] [Related]  

  • 11. A double-blind study of chlorthalidone and hydrochlorothiazide in an outpatient population of moderate hypertensives.
    Finnerty FA
    Angiology; 1976 Dec; 27(12):738-44. PubMed ID: 802926
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of two combined diuretics in the treatment of essential hypertension.
    Verhiest W; Baehre M; Volkers P
    Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):342-5. PubMed ID: 2674028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose atenolol-chlorthalidone combination for treatment of mild hypertension.
    Leonetti G; Pasotti C; Capra A
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):43-7. PubMed ID: 3514487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atenolol and chlorthalidone administered alone and in combination for essential hypertension.
    Boike SC; Durley Y; Cubberley RB
    Clin Pharm; 1982; 1(5):449-53. PubMed ID: 6764166
    [No Abstract]   [Full Text] [Related]  

  • 15. Double-blind comparison of triamterene plus hydrochlorothiazide and spironolactone plus hydrochlorothiazide in the treatment of hypertension.
    Cocke TB; Fisch S; Gilmore HR; Okun R; Tamagna IG; Wipplinger K
    J Clin Pharmacol; 1977; 17(5-6):334-8. PubMed ID: 323298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piretanide, a potassium stable diuretic, in the treatment of essential hypertension.
    Verho M; Rangoonwala B; Dols W; Fratzer U; Kaczynski J; Mühlhäusler W
    Eur J Clin Pharmacol; 1984; 27(4):407-14. PubMed ID: 6394349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of mild-to-moderate hypertension: comparison between a calcium-channel blocker and a potassium-sparing diuretic.
    Boulet AP; Chockalingam A; Fodor JG; Laplante L; Houde M; Lenis J; Logan AG; Robitaille MN; Ryan D; Spénard J
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S45-50. PubMed ID: 1725543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once daily combination therapy for hypertension.
    Asbury MJ; Wells FO; Barker NP
    Practitioner; 1980 Dec; 224(1350):1306-9. PubMed ID: 7012818
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-acting and short-acting diuretics in the treatment of hypertension.
    Pupita F; Belogi M; Ansuini R; Campolucci G
    Pharmatherapeutica; 1983; 3(7):475-81. PubMed ID: 6366805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advantages of a fixed association of oxprenolol-chlorthalidone, as opposed to chlorthalidone alone, in the treatment of chronic essential arterial hypertension].
    Baronchelli A; Agosta R; Verdecchia P; Bichisao E
    Clin Ter; 1981 Apr; 97(1):63-9. PubMed ID: 7026137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.